Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

A man lost a lot of scalp hair quickly after stopping minoxidil, but it grew back with mild male pattern baldness.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Hair loss causes stress and affects mental health; treatment and support needed.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

The drinkable supplement increased hair growth and was safe for women with hair loss.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Personality traits and anxiety affect hair loss patients' quality of life.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Miliacin with polar lipids helps hair growth and improves hair loss in women.

Low iron levels are linked to hair loss in women.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.